亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

湖北康寶泰精細(xì)化工有限公司(銷售部)  

醫(yī)藥原料及中間體、植物提取物、維生素等

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:陳先生
  • 電話:027-87738693
  • 傳真:027-87738652
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 供應(yīng)鹽酸可樂定廠家CAS編號(hào): 4205-91-8
供應(yīng)鹽酸可樂定廠家CAS編號(hào): 4205-91-8
單價(jià) 面議對比
詢價(jià) 暫無
發(fā)貨 湖北武漢市預(yù)售,付款后7天內(nèi)
型號(hào) CAS編號(hào): 4205-91-8
規(guī)格 醫(yī)藥級(jí)
過期 長期有效
更新 2011-01-30 16:15
 
詳細(xì)信息

鹽酸可樂定
英文名:Clonidine Hydrochloride
產(chǎn)品含量: 99%
化學(xué)式: C9H9Cl2N3.HCl
CAS編號(hào): 4205-91-8
質(zhì)量標(biāo)準(zhǔn): BP98
包裝規(guī)格: 25KG/桶
【適應(yīng)癥】1.高血壓(不作為第一線用藥)2.高血壓急癥。3.偏頭痛、絕經(jīng)期潮熱、痛經(jīng)
©2025 湖北康寶泰精細(xì)化工有限公司(銷售部) 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:22910  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |